APPLICATION
ANDA214950
TYPE
ANDA
ORIGINAL APPROVAL
2023-01-30
LATEST ACTION
2023-01-30
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Prescription
Products
THEOPHYLLINEPrescription
THEOPHYLLINE 300MG · TABLET, EXTENDED RELEASE · ORAL
THEOPHYLLINEPrescription
THEOPHYLLINE 450MG · TABLET, EXTENDED RELEASE · ORAL
Approval history
2023-01-30UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.